Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Iron Prophylaxis for High Altitude Insertions
NCT06686693Phase 4Recruiting
- Sponsor
- U.S. Army Research Institute of Environmental Medicine
- Start
- Apr 2022
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ferric carboxymaltose in hypoxia, sponsored by U.S. Army Research Institute of Environmental Medicine. Primary endpoint: 2-mile treadmill time trial performance. Started Apr 2022; status: recruiting.
02
Drugs
ferric carboxymaltose
03
Conditions
hypoxia
Beyond the preview
Go deeper on NCT06686693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06686693.